ROC curve and Risk Analyses

Autoantibodies Prognostic Accuracies AUC 95% CI P Anti-apoA-1 IgG, Index Anti-HSP-60 antibodies, ng/ml Anti-β2GPI IgG, units Anti-βGPI IgM, units Anti-βGPI IgA, units Anti-cardiolipin IgG, units Anti-cardiolipin IgM, units Anti-cardiolipin IgA, units Anti-β2GPI D4/5 IgA, units Anti-PC IgM, U/ml 0.65 0.58 0.54 0.51 0.53 0.58 0.59 0.54 0.55 0.52 0.53-0.76 0.48-0.69 0.43-0.65 0.40-0.63 0.42-0.64 0.47-0.69 0.48-0.70 0.42-0.66 0.45-0.65 0.37-0.59 0.007 0.06 0.23 0.41 0.29 0.08 0.05 0.27 0.16 0.37 Cox Regression analyses for MACE prediction Unadjusted Hazard Ratio P *Adjusted Hazard Ratio P Anti-apoA-1 IgG positivity 3.92 0.001 3.80 0.002 *Adjusted for the 10-year global Framingham risk score

Table 2: